Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (3687)	1/14/2000 1:37:00 AM
From: Rich Wolf	Read Replies (4) \| Respond to of 4140

Are you completely dense, A+P? The structure of the deal was based on previous share prices: when they didn't obtain approval in July, the stock tanked to $4... hence for this deal, Lehman felt comfortable being given a FLOOR of conversion at 25% less than that $4 price, namely $3. Period. But now with acceptance, the stock will never go there again. Probably never even retest the single digits again. So take your 'floorless' noise elsewhere. I recommend you cover soon, and go elsewhere. Shorting stock is one of the best ways to go broke quickly: your downside risk is literally unlimited! And you speak of 'value investing'? What are you doing in biotech? This is all spec, momentum, and growth. However, this is indeed a valuable play to be invested in: the long-term potential is phenomenal. It'll blow past the lasik companies in a few years' time. Just watch... from a distance... you SHORT you! Now I recommend you go to bed and get some sleep... if you can! LOL!